Experimental model of cardiovascular post-resuscitation syndrome - No effect of platelet activating factor antagonism

Resuscitation

Volumn 39, Issue 1-2, 1998, Pages 115-123

  Gedeborg, Rolf ^a   Wiklund, Lars ^a  

^a U Anaesthiol Intensive Care U ^*  (Sweden)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Myocardial stunning; Open chest cardiac compression; Platelet activating factor; Post resuscitation period

Indexed keywords

GINKGOLIDE B; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEART ARREST; HEMODYNAMIC MONITORING; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; STUNNED HEART MUSCLE; SWINE; TREATMENT OUTCOME;

ACID-BASE EQUILIBRIUM; ANIMALS; BLOOD GAS ANALYSIS; BRAIN DISEASES; DISEASE MODELS, ANIMAL; DITERPENES; ELECTROCARDIOGRAPHY; GINKGOLIDES; HEART ARREST; HEMODYNAMIC PROCESSES; HEMOGLOBINS; LACTONES; PLATELET ACTIVATING FACTOR; REPERFUSION INJURY; RESUSCITATION; SWINE;

EID: 0032439909     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(98)00127-0     Document Type: Article

References (34)

1. Cooper S, Cade J Predicting survival, in-hospital cardiac arrests: resuscitation survival variables and training effectiveness. Resuscitation. 35:1997;17-22.
2. Ames AI, Nesbett FB Pathophysiology of ischemic cell death: I. Time of onset of irreversible damage; importance of the different components of the ischemic insult. Stroke. 14:1983;219-226.
3. Hossmann KA, Kleihues P Reversibility of ischemic brain damage. Arch Neurol. 29:1973;375-384.
4. Cerchiari EL, Safar P, Klein E, Cantadore R, Pinsky M Cardiovascular function and neurologic outcome after cardiac arrest in dogs: the cardiovascular post-resuscitation syndrome. Resuscitation. 25:1993;9-33.
5. Gazmuri RJ, Weil MH, Bisera J, Tang W, Fukui M, McKee D Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med. 24:1996;992-1000.
6. Ontell SJ, Makowka L, Trager J, Mazzaferro V, Ove P, Starzl TE Pharmacologic modulation of experimental postischemic hepatic function. Ann Surg. 209:1989;200-210.
7. Feuerstein G, Siren AL Platelet-activating factor and shock. Prog Biochem Pharmacol. 22:1988;181-190.
8. Lefer AM Significance of lipid mediators in shock states. Circ Shock. 27:1989;3-12.
9. Mozes T, Braquet P, Filep J Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol. 2:1989;872-877.
10. Terashita Z, Stahl GL, Lefer AM Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock. J Cardiovasc Pharmacol. 12:1988;505-511.
11. Stahl GL, Bitterman H, Lefer AM Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock. Thromb Res. 53:1989;327-338.
12. Bitterman H, Lefer DJ, Lefer AM Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. Meth Find Exp Clin Pharmacol. 9:1987;341-347.
13. Stahl GL, Bitterman H, Terashita Z, Lefer AM Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. Eur J Pharmacol. 149:1988;233-240.
14. Armstead WM, Pourcyrous M, Mirro R, Leffler CW, Busija DW Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. Circ Res. 62:1988;1-7.
15. Kochanek PM, Dutka AJ, Kumaroo KK, Hallenbeck JM Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. Life Sci. 41:1987;2639-2644.
16. Ezra D, Laurindo FR, Czaja JF, Snyder F, Goldstein RE, Feuerstein G Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. Prostaglandins. 34:1987;41-57.
17. Wainwright CL, Parratt JR, Bigaud M. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. Biomed Biochim Acta 1988;47:S224-S227.
18. Wainwright CL, Parratt JR, Bigaud M The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. Eur Heart J. 10:1989;235-243.
19. Morrison PR, Meyer MP. Constants for use in body surface area formula: Mammals. In: Altman PL, Dittmer DS, editors. Biology Data Book. Washington: Federation American Society Experimental Biology, 1964:121.
20. Kern KB, Hilwig RW, Rhee KH, Berg RA Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol. 28:1996;232-240.
21. Braunwald E, Kloner RA The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 66:1982;1146-1149.
22. Abu Zidan FM, Walther S Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs. Eur J Surg. 162:1996;499-504.
23. Abu Zidan FM, Walther S, Lennquist S Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs. J Trauma. 41:1996;634-640.
24. Herbertson MJ, Werner HA, Walley KR Platelet-activating factor antagonism improves ventricular contractility in endotoxemia. Crit Care Med. 25:1997;221-226.
25. Kruse Elliott KT, Albert DH, Summers JB, Carter GW, Zimmerman JJ, Grossman JE Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. Shock. 5:1996;265-273.
26. Schurr MJ, Fabian TC, Croce MA, Geraci SA, Proctor KG Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. Surgery. 121:1997;493-500.
27. Abu Zidan FM, Walther S, Lennquist S Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs. Eur Surg Res. 29:1997;133-141.
28. Godin PJ, Buchman TG Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 24:1996;1107-1116.
29. Mozes T, Heiligers JP, Tak CJ, Zijlstra FJ, Ben Efraim S, Saxena PR et al. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. J Lipid Mediat. 4:1991;309-325.
30. Jehle D, Fiorello AB, Brader E, Cottington E, Kozak RJ Hemoconcentration during cardiac arrest and CPR. Am J Emerg Med. 12:1994;524-526.
31. Mózes T, Zijlstra FJ, Heiligers JPC Interactions between platelet activating factor and eicosanoids during endotoxic shock in anaesthetized pigs. Mediat Inflamm. 1:1992;183-190.
32. 2 reactivity following onset of the delayed postischemic hypoperfusion state in dogs. J Cereb Blood Flow Metab. 13:1993;260-268.
33. 2 reactivity and autoregulation. Stroke. 6:1975;425-431.
34. Fischer EG, Ames A, III, Lorenzo AV. Cerebral blood flow immediately following brief circulatory stasis. Stroke 1979;10:423-427.